 Home > Biochemistry News > Biotechnology News > FDA granted fast track qualification for the new immunotherapy nemvaleukin+Keytruda program

FDA granted fast track qualification for the new immunotherapy nemvaleukin+Keytruda program

 Last Update: 2021-12-04
 Source: Internet
 Author: User

Tags

dwarfism treatment

aeromonas hydrophila treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Alkermes recently announced that the US Food and Drug Administration (FDA) has granted nemvaleukin alfa (nemvaleukin) fast track designation (FTD), combined with Merck’s anti-PD-1 therapy Keytruda (generic name: pembrolizumab, pembrolizumab) Anti), used to treat platinum-resistant ovarian cancer

Nemvaleukin is a new type of engineered interleukin-2 (IL-2) variant immunotherapy

Fast Track Qualification (FTD) aims to accelerate drug development and rapid review for serious diseases to address serious unmet medical needs in key areas

Structure characteristics and mechanism of nemvaleukin

Nemvaleukin is a new type of engineered fusion protein under research, consisting of a modified interleukin-2 (IL-2) and a high-affinity interleukin-2α receptor chain, designed to selectively bind to medium-affinity IL-2 The receptor complex preferentially expands tumor-killing immune cells while avoiding the activation of immunosuppressive cells

ARTISTRY is a clinical development project sponsored by Alkermes to evaluate nemvaleukin as a potential cancer immunotherapy

Note: The original text has been deleted

Original source: Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.